Process Mass Intensity (PMI): A Holistic Analysis of Current Peptide Manufacturing Processes Informs Sustainability in Peptide Synthesis
Open accessThe DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Small molecule therapeutics represent the majority of the FDA-approved drugs. Yet, many attractive targets are poorly tractable by small molecules, generating a need for new therapeutic modalities. Due to their biocompatibility profile and structural versatility, peptide-based therapeutics are a possible solution. Additionally, in the past two decades, advances in peptide design, delivery, formulation, and devices have occurred, making therapeutic peptides an attractive modality. However, peptide manufacturing is often limited to solid-phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and to a lesser extent hybrid SPPS/LPPS, with SPPS emerging as a predominant platform technology for peptide synthesis. SPPS involves the use of excess solvents and reagents which negatively impact the environment, thus highlighting the need for newer technologies to reduce the environmental footprint. Herein, fourteen American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable (ACS GCIPR) member companies with peptide-based therapeutics in their portfolio have compiled Process Mass Intensity (PMI) metrics to help inform the sustainability efforts in peptide synthesis. This includes PMI assessment on 40 synthetic peptide processes at various development stages in pharma, classified according to the development phase. This is the most comprehensive assessment of synthetic peptide environmental metrics to date. The synthetic peptide manufacturing process was divided into stages (synthesis, purification, isolation) to determine their respective PMI. On average, solid-phase peptide synthesis (SPPS) (PMI ≈ 13,000) does not compare favorably with other modalities such as small molecules (PMI median 168-308) and biopharmaceuticals (PMI ≈ 8300). Thus, the high PMI for peptide synthesis warrants more environmentally friendly processes in peptide manufacturing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green Chemistry: Theory and Practice
Anastas, P. T., & Warner, J. C. (1998) · Medical Entomology and Zoology · Cited by 8,599
Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 1,964
Houghten, R. A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T., & Cuervo, J. H. (1991) · Nature · doi:10.1038/354084a0 · Cited by 1,326
Metrics of Green Chemistry and Sustainability: Past, Present, and Future
Sheldon, R. A. (2018) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.7b03505 · Cited by 1,292
Peer Reviewed: Design Through the 12 Principles of Green Engineering
Anastas, P. T., & Zimmerman, J. B. (2003) · Environmental Science & Technology · doi:10.1021/es032373g · Cited by 1,273
Metrics to ‘green’ chemistry—which are the best?
Constable, D. J. C., Curzons, A. D., & Cunningham, V. L. (2002) · Green Chem. · doi:10.1039/b206169b · Cited by 910
Jimenez-Gonzalez, C., Ponder, C. S., Broxterman, Q. B., & Manley, J. B. (2011) · Organic Process Research & Development · doi:10.1021/op200097d · Cited by 910
Isidro-Llobet, A., Álvarez, M., & Albericio, F. (2009) · Chemical Reviews · doi:10.1021/cr800323s · Cited by 850
Self-citationLarge-Scale Applications of Amide Coupling Reagents for the Synthesis of Pharmaceuticals
Dunetz, J. R., Magano, J., & Weisenburger, G. A. (2016) · Organic Process Research & Development · doi:10.1021/op500305s · Cited by 819
Research works printed but not linked: 7
- Blaha K., 2004, Chemicke Listy, 98, 875
- Sisniega E. C., 2008, Dyna, 83, 382
- Aguilar M. I., 2004, Methods in Molecular Biology, HPLC of Peptides and Proteins, Methods and Protocols
- Ludemann-Hombourger O., 2021, Chemistry Today, 39, 50
- Agency E. C., Restrictions on the Manufacture, Placing on the Market and Use of Certain Dangerous Substances, Mixtures and Articles
- Ravetti Duran R., 2022, Speciality Chemicals Magazine, 2022, 40
- Al Musaimi O., 2021, Chemistry Today, 39, 42
Cited by
Items 101–165 of 165
Utility of fluorinated α-amino acids in development of therapeutic peptides
Richardson, P. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2601105 · Cited by 1
Self-citationTiwari, T., Kumar, Y., & Pushpavanam, K. (2025) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.5c10844 · Cited by 1
Gazetas, L., Ruppel, M., Richtzenhain, C., Hampel, F., Jux, N., & Lungerich, D. (2026) · Chemistry - A European Journal · doi:10.1002/chem.70979 · Cited by 1
“In case of high-value target compounds, such as peptide-based drugs, values can, however, often exceed values > 1000 [63].”
The Application of Amoc Amino Acids in the Synthesis of Polypeptides
向双春, Gao, F., Tian, F., Liu, C., Xiang, F., Shi, G., Teng, Y., Liu, X., & Dong, L. (2026) · ACS Omega · doi:10.1021/acsomega.6c03172 · Cited by 1
Arbour, C. A., Gudorf, J. A., Guthrie, Q. A. E., Curtis, R. W., Choudhary, S., Jansen, P. J., Desmond, J. A., Elkhalifa, M., Jalan, A., Murzinski, E. S., et al. (2026) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.6c08131 · Cited by 1
Self-citationLi, J., Verma, V., & Heng, J. Y. Y. (2026) · ACS Omega · doi:10.1021/acsomega.6c05745 · Cited by 1
Regueiro, C. L. F., Macis, M., Arnofi, C., Toplak, A., Cabri, W., Paradisi, F., Padrosa, D. R., & Ricci, A. (2026) · Organic Process Research & Development · doi:10.1021/acs.oprd.6c00249 · Cited by 1
Hydrophobic Tag‐Assisted Scalable Synthesis of Trofinetide and Its GPE Analogues
Avula, V., Vangapelly, S. K., Mang, Y., Umamaheshwar, S., Nagendra, G., & Rao, H. S. P. (2026) · Journal of Peptide Science · doi:10.1002/psc.70096 · Cited by 1
Swelling Thermodynamics and Kinetics of Crosslinked Polystyrene Resin in Solid‐Phase Synthesis
Pinzón-López, S., Ebert, D., Kraume, M., Seeberger, P. H., & Danglad‐Flores, J. (2026) · Macromolecular Chemistry and Physics · doi:10.1002/macp.70283 · Cited by 1
“…drug targets [ 22–24 ] drives the need for significantly faster synthesis cycles [ 25–27 ], reduced excess of valuable starting materials [ 28–30 ], the use of resin volume changes as a real-time monitoring tool [ 31–33 ] and, in general, a proper physical description of the swelling process…”
Mottola, S., Mazzarella, V., Cutolo, R., Torino, M., Rosa, O. D., Cosconati, S., Maro, S. D., & Messere, A. (2026) · Green Chemistry · doi:10.1039/d6gc05265g · Cited by 1
The Stubborn Persistence of Toxic Solvents in Chemical Synthesis
Dobbelaere, M. R., & Sneddon, H. F. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.1677569 · Cited by 1
Peptide-Based Drugs: Development and Therapeutic Applications
Kanojia, A., Singh, S., Rai, V., & Yadav, A. (2024) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.3.4.7 · Cited by 1
Chemische Proteinsynthese/Trendbericht Biochemie 2024 (1/3)
Hartrampf, N. (2024) · Nachrichten aus der Chemie · doi:10.1002/nadc.20244143478
Cost-Effective Synthesis of Bule-OH: An Alternative to Bulevirtide for Hepatitis B and D Research
Zhu, H., Hua, H., Dong, Y., Xu, H., & Feng, J. (2025) · Pharmaceutical Fronts · doi:10.1055/a-2594-1472
“14 In 2022, the Food and Drug Administration declined to approve Bulevirtide for marketing in the United States, citing concerns over its manufacturing and distribution processes.”
Total Synthesis of Feglymycin Using Umpolung Amide Synthesis
Gourville, P. C., Bing, J. A., Quarels, R. D., Tsukanov, S. V., Schwieter, K. E., Tokumaru, K., Stephens, A. B., Makley, D. M., Shen, B., Smith, A. N., et al. (2025) · Angewandte Chemie · doi:10.1002/ange.202508819
Parente, M. J., & Sitharaman, B. (2025) · ACS Omega · doi:10.1021/acsomega.5c02172
Advances in peptide-based drug discovery
Khatri, B., Velloso, J. P. L., Shambhawi, Kan, M., & Craik, D. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00041-8
Sustainable Peptide synthesis and design: Integrating green synthesis and computational tools
Choudhury, P. R., Mishra, S. K., Singh, S., & Mathur, P. (2025) · Current Trends in Biotechnology and Pharmacy · doi:10.5530/ctbp.2025.3s.15
Characterizing new conotoxin interactions with G protein-coupled receptors by using PRESTO-Tango
Akoa Mbida, A. (2025) · DiVA (Digitala Vetenskapliga Arkivet)
Zingales, S. K., Gibson, M., Tapia-Hernandez, J., Jenkins, K., Munzing, M., Dickerson, G., Speikers, S., Frazer, D., Padgett, C. W., & Wentzel, M. T. (2026) · ACS Omega · doi:10.1021/acsomega.5c07008
Bis(phenolate)–Titanium(IV) Catalysts for Efficient and Sustainable Direct Amide Bond Formation
Colombo, G., Fasola, E., Leuzzi, L., Arrigoni, F., Gazzola, S., & Piarulli, U. (2026) · ChemistrySelect · doi:10.1002/slct.202506605
Renewable materials-based synthesis of 3-ureidopropanoic acid
Mironiuk‐Puchalska, E., Święcicka-Füchsel, E., Zalewska, A., & Koszytkowska‐Stawińska, M. (2026) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2026.102344
Mohammadi, M., Swist, N., Rasmussen, J. H., & Pawlas, J. (2026) · Organic Process Research & Development · doi:10.1021/acs.oprd.5c00433
Evaluation of Titanium Oxo Clusters as Catalysts for Direct Amidations
Peeters, A. P. A., Vendrame, D., Carraro, M., Gross, S., & de Azambuja, F. (2026) · Synlett · doi:10.1055/a-2818-7276
Shahriar, M. F., Kabir, J., & Kong, Y. (2026) · Molecular Diversity · doi:10.1007/s11030-025-11455-5
“This phase uses excessive amounts of solvents and reagents, which not only raise the cost of the medicines but also pose environmental hazards [117, 118 ].”
Zhang, K., Barbieri, E., Minzoni, A., Brino, B., Shastry, S., Hurst, M. R., Gracieux-Singleton, M. C., Rameez, S., Mostafa, S. S., & Menegatti, S. (2026) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2026.03.008
Ferentzi, K. (2025) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2025.039
Kurniawan, R., Utomo, D. S., & Kusumaatmaja, A. (2026) · Sustainable materials and technologies · doi:10.1016/j.susmat.2026.e02051
Tussholiha, N. (2026) · Journal of Chemical Learning Innovation. · doi:10.37251/jocli.v3i1.3170
“These materials are used as primary reagents in the synthesis process and as solvents in the purification and analysis stages of the compounds [28].”
Therapeutic development for hypertension by targeting the peptide-mediated blood pressure control
Akira, S. A. T. O., & Ogita, H. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118115
Aziz, Z. H. A., Uddin, A. B. M. H., Ahmed, Q. U., Begum, T., & Sabere, A. S. M. (2026) · Journal of Solution Chemistry · doi:10.1007/s10953-026-01619-8
“These practices often involve excessive use of hazardous reagents, solvents, catalysts, and byproducts, frequently exceeding the regulatory threshold of 1% (w/w) for residual reagents [9, 10].”
Digital Twin Technology for TIDES Process Development and Manufacturing
Uhl, A., Broocks, M., Schulz, T. O. J., Mendoza, A. M., Schmidt, A., & Strube, J. (2026) · Processes · doi:10.3390/pr14121873
A Short Synthesis of Cyclo(‐RGDfK) Using a Microflow Reactor
Yamasaki, N., Kim, M., Miyamoto, K., Otake, Y., Adachi, K., Kubo, D., & Fuse, S. (2026) · ChemistryEurope · doi:10.1002/ceur.70326
“In addition, because protected amino acids are used for peptide chain elongation, nearly half of the total synthetic steps are devoted to deprotection, leading to longer reaction times, increased steps, and waste [6 – 11].”
Sustainable and scalable transformations in aqueous media enabled by continuous flow processing
Ötvös, S. B., & Kappe, C. O. (2026) · Current Opinion in Green and Sustainable Chemistry · doi:10.1016/j.cogsc.2026.101081
Prestia, R., Hauri, D., Sponchioni, M., Vogg, S., & Müller‐Späth, T. (2026) · Separations · doi:10.3390/separations13070195
Zhu, X., Xue, S., Wang, W., Zhang, X., Cui, Z., Chen, Z. F., & Debnath, S. (2026) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6c01293
A simplified model for solid phase synthesis flow reactors
Pinzón-López, S., Hsu, W., Ebert, D., Kraume, M., Seeberger, P. H., & Danglad‐Flores, J. (2026) · Reaction Chemistry & Engineering · doi:10.1039/d6re00159a
Zhao, J., Chen, L., Lin, L., Jiang, Y., Liang, F., Liu, W., 谷瑞增, & Zhang, X. (2026) · Food Reviews International · doi:10.1080/87559129.2026.2699344
Gore, V., Tusé, D., Giritch, A., Nandi, S., & McDonald, K. A. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1868916
“This method has been used as a sustainability metric for a wide range of biomanufacturing processes ranging from peptide synthesis (22) to plant-made biopharma-ceuticals (23).”
Bettin, G., Salvadoretti, M., Rossi, G., Fabris, F., Bonetto, A., Brancolini, C., Scarso, A., & Angelini, A. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110323
Anderson, N. G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36522-5.00003-6
Zhou, Y., Jiang, X., Zhang, X., Yao, X., Gao, Z., Chen, X., Gong, L., Jie, J., Yang, Y., & Yang, P. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.08.027
“These approaches are suitable for mechanistic studies, but they may not be appropriate for scaled production [189].”
Zhong, J., & Li, Y. (2026) · Polymers · doi:10.3390/polym18162030
“This not only simplifies the process but also reduces reliance on auxiliary reagents and solvents [37,43,91].”
InfluentialKapoor, S., & Dubey, A. (2026) · Chemistry Africa · doi:10.1007/s42250-026-01794-7
Lück, R., Oliver Spadiut, A., Imran, F., Harasek, M., Pappas, A., Chatzipanagiotou, K., Antonaropoulos, G., Koumoulos, E. P., Kalogridis, S., Chadoulos, S., et al. (2026) · New Biotechnology · doi:10.1016/j.nbt.2026.09.003
Synthetic Targeted Peptides in Therapy
Shiryaeva, O. S., Smirnov, E. A., Znamensky, V. A., Murashko, E. A., Kolobov, A. A., Бондаренко, А. Б., Korolev, D. V., Galagudza, M. M., & Cheburkin, Y. V. (2026) · Nanobiotechnology Reports · doi:10.1134/s2635167626602366
Tumor-homing peptides in precision oncology
Ma, G., Derkaoui, D. K., SENHADJI, R., Karoyan, P., & Poyet, J. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115360
Canales, C. S. C., Yagi, A. C. L., Reis, T. C., Cazorla, J. I. M., Villar, J. R., Graminha, M. A. S., Alta, R. Y. P., & Pavan, F. R. (2026) · ChemMedChem · doi:10.1002/cmdc.70493
“Solid-phase peptide synthesis remains the dominant platform but consumes large volumes of solvent and reagent; a cross-industry analysis of process mass intensity across 14 companies quantified this foot-print and identified it as the principal sustainability constraint of the modality [236].”
The Stubborn Persistence of Toxic Solvents in Chemical Synthesis
Dobbelaere, M. R., & Sneddon, H. F. (2026) · Angewandte Chemie · doi:10.1002/ange.1677569
From Soil to Shelf: Teixobactin at Ten─Mechanism, SAR, and the Road to Clinical Application
Binette, R., Lacasse, E., Malouin, F., & Boudreault, P. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00389
Hansell, L., Zhu, W., Lynch, M., Hocking, S., Celermajer, D. S., & Sack, F. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-124968
Ali, D., E-Farwa, U., Kumari, M., & Khan, M. A. (2026) · Chemical Papers · doi:10.1007/s11696-026-05723-3
Ndaleh, D., Desmond, J. A., Wall, B. J., Salim, H., Murzinski, E. S., Gudorf, J. A., Jansen, P. J., Belvo, M. D., Kobierski, M. E., Lee, J., et al. (2026) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.6c05800
Self-citationRedox-responsive peptide assemblies for precision theranostic
Haddadzadegan, S., Huang, C., Ghafouri, M., & Miserez, A. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115977
Recent Advances in the Synthesis of Therapeutic Peptides and Oligonucleotides
Ramesh, A., Behera, P., Siddija, R., Ghosh, S., & Tiwari, O. S. (2026) · Organic Process Research & Development · doi:10.1021/acs.oprd.6c00322
Mali, P., & Sreedhar, I. (2026) · Journal of Electrochemical Science and Engineering · doi:10.5599/jese.3596
“Therefore, the improvement of the synthesis of peptides is an important topic of research for both academic and pharmaceutical fields [1,2].”
Zhu, Q., Yu, Y., Liu, T., & Zhao, Y. (2026) · Green Chemistry · doi:10.1039/d6gc04168j
Synthesis of a Crystalline Acylated Lysine Building Block for Retatrutide Manufacture
Wang, J., Teng, J., Guinn, E. J., Curtis, R. W., Richey, R. N., Tsukanov, S. V., Calvin, J. R., Lambertus, G. R., Strege, M. A., Jalan, A., et al. (2026) · Organic Process Research & Development · doi:10.1021/acs.oprd.6c00240
Self-citationLi, L., Zheng, R., 孙荣芹, & Luo, Y. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.183652
Hung, W.-R., Chou, C.-T., & Tsai, C. (2026) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6c01477
Peptide–chitosan conjugates: From synthesis and characterization to biomedical applications
Zhu, M., Zhou, Y., Xu, F., Xu, K., Mei, J., & Qian, J. (2026) · Applied Materials Today · doi:10.1016/j.apmt.2026.103476
Pawlas, J., Wahlqvist, L., Nilsson, O., & Haugaard‐Kedström, L. M. (2026) · ACS Omega · doi:10.1021/acsomega.6c08146
Total synthesis of cochinmicin I and V
Williams, J. C., Gourville, P. C., Pyrah, C. K., Stark, W. J., Bing, J. A., & Johnston, J. N. (2026) · Chemical Science · doi:10.1039/d6sc05662h
Kumar, A., Fidha, F., Leko, M. V., Marder, O., Burov, S. V., Sharma, A., de la Torre, B. G., & Alberício, F. (2026) · Chemistry - Methods · doi:10.1002/cmtd.70179
Metadata
- Authors
- Kekessie, I., Wegner, K., Martinez, I., Kopach, M. E., White, T. D., Tom, J. K., Kenworthy, M. N., Gallou, F., Lopez, J., Koenig, S. G., Payne, P. R., Eissler, S., Arumugam, B., Li, C., Mukherjee, S., Isidro-Llobet, A., Ludemann-Hombourger, O., Richardson, P., Kittelmann, J., Sejer Pedersen, D., & van den Bos, L. J.
- Affiliations
- Roche (United States) (US)
- Ipsen (Ireland) (IE)
- Green Chemistry Institute, American Chemical Society, 1155 16th St North West, Washington, District of Columbia, 20036, United States
- Eli Lilly (United States) (US)
- Amgen (United States) (US)
- AstraZeneca (United Kingdom) (GB)
- Novartis (Switzerland) (CH)
- Outsourced Manufacturing, Pharmaceutical Development & Manufacturing, Gilead Alberta ULC, 1021 Hayter Rd NW, Edmonton, T6S 1A1, Canada
- Bachem (Switzerland) (CH)
- Tianjin Economic-Technological Development Area (CN)
- Bristol-Myers Squibb (United States) (US)
- GSK, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
- PolyPeptide Laboratories France SAS, 7 Rue de Boulogne, 67100 Strasbourg, France
- Pfizer (United States) (US)
- CMC API Development, Novo Allé, 2880 Bagsværd, Denmark
- Chemical Development, Novo Allé, CMC API Development, 2880 Bagsværd, Denmark
- EnzyTag B.V, Daelderweg 9, 6361HK, Nuth, Netherlands
- Corresponding author
- Kekessie, Ivy
- ORCID
- Venue
- The Journal of Organic Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2024-03-20
- Volume
- 89
- Issue
- 7
- Pages
- 4261-4282
- ISSN
- 0022-3263 (ISSN-L)
- 1520-6904
- PMC
- PMC11002941
- OpenAlex
- W4393022591
- Cited by
- 149
- References
- 126
- Citations by year
- 2026: 74 · 2025: 60 · 2024: 15
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Organic Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- The Novartis Repository (Novartis) (submittedVersion)
- Funders
- American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Chemistry and Chemical Engineering
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Physical Sciences › Environmental Science › Environmental Engineering › Environmental Impact and Sustainability
- Keywords
- process mass intensity, solid-phase peptide synthesis, liquid-phase peptide synthesis, green chemistry, environmental footprint, peptide therapeutics, peptide purification
- MeSH terms
- Peptides, Solvents, Chemistry Techniques, Synthetic, Solid-Phase Synthesis Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.